| Literature DB >> 29225701 |
Yan Feng1, Anthony Mannion1, Carolyn M Madden1, Alton G Swennes1,2, Catherine Townes1, Charles Byrd1,3, Robert P Marini1, James G Fox1.
Abstract
BACKGROUND: Many Escherichia coli strains are considered to be a component of the normal flora found in the human and animal intestinal tracts. While most E. coli strains are commensal, some strains encode virulence factors that enable the bacteria to cause intestinal and extra-intestinal clinically-relevant infections. Colibactin, encoded by a genomic island (pks island), and cytotoxic necrotizing factor (CNF), encoded by the cnf gene, are genotoxic and can modulate cellular differentiation, apoptosis and proliferation. Some commensal and pathogenic pks+ and cnf+ E. coli strains have been associated with inflammation and cancer in humans and animals.Entities:
Year: 2017 PMID: 29225701 PMCID: PMC5718112 DOI: 10.1186/s13099-017-0220-y
Source DB: PubMed Journal: Gut Pathog ISSN: 1757-4749 Impact factor: 4.181
Prevalence of E. coli strains isolated from macaques
| 2012 | 2014 | 2016 | Total | |
|---|---|---|---|---|
|
| 51/84 (60.7%) | 72/85 (85.7%) | 73/97 (75.3%) | 196/266 (73.7%) |
| β-hemolytic | 4/66 (6.1%) | 16/84 (19.0%) | 23/89 (25.8%) | 43/239 (18.0%) |
Prevalence of pks and cnf1 genes in E. coli isolates from macaques
| 2012 | 2014 | 2016 | Total | |
|---|---|---|---|---|
|
| 11/66 (16.7%) | 22/84 (26.2%) | 8/89 (9.0%) | 41/239 (17.2%) |
|
| 0/66 (0.0%) | 5/84 (6.0%) | 14/89 (15.7%) | 19/239 (7.9%) |
|
| 7/66 (10.6%) | 14/84 (16.7%) | 10/89 (11.2%) | 31/239 (13.0%) |
| Total | 18/66 (27.2%) | 36/84 (42.9%) | 18/89 (20.2%) | 72/239 (30.1%) |
| Total | 7/66 (10.6%) | 19/84 (22.6%) | 24/89 (27.0%) | 50/239 (20.9%) |
Fig. 1Amplification of clbQ and cnf1 genes in E. coli isolates from macaques. Top row: clbQ gene, bottom row: cnf1 gene. Lanes 1 and 2, S7 and S8 (pks-/cnf1−); lanes 3 and 4, S9 and S10 (pks−/cnf1+); lanes 5 and 6, S4 and S5 (pks+/cnf1−); lanes 7 and 8, S1 and S2 (pks+/cnf1+); lane 9, pks and cnf1 positive controls; lane 10, negative controls; lane 11, 1 kb+ molecular marker
Fig. 2Phylogenetic group determination of E. coli isolates from macaques. Lane 1, group D macaque E. coli; lanes 2 and 3, group A macaque E. coli; lanes 4 and 5, group B1 macaque E. coli; lanes 6 and 7, group B21 macaque E. coli; lanes 8 and 9, group B2 macaque E. coli; lane 10, group A control E. coli K12; lane 11, group B2 control E. coli NC101; lane 12, group B21 control E. coli RS218 (from human meningitis); lane 13, 1 kb+ molecular marker
Phylogenetic distribution of E. coli isolates from macaques
| Phylogenetic group | 2014 | 2016 | Total |
|---|---|---|---|
| A | 5/84 (6.0%) | 18/89 (20.2%) | 23/173 (13.3%) |
| B1 | 23/84 (27.4%) | 22/89 (24.7%) | 45/173 (26.0%) |
| B2 | 37/84 (44.0%) | 28/89 (31.5%) | 65/173 (37.6%) |
| B21 | 18/84 (21.4%) | 21/89 (23.6%) | 39/173 (22.5%) |
| D | 1/84 (1.2%) | 0/89 (0.0%) | 1/173 (0.6%) |
Fig. 3The phylogenetic distribution of E. coli isolates from macaques in 2014 and 2016
Distribution of pks, cnf1 genes and β-hemolysis in E. coli isolates according to phylogenetic group
| Phylogenetic group |
|
| β-hemolytic | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 2014 | 2016 | Total | 2014 | 2016 | Total | 2014 | 2016 | Total | |
| A | 0/36 (0.0%) | 1/18 (5.6%) | 1/54 (1.9%) | 0/19 (0.0%) | 0/24 (0.0%) | 0/43 (0.0%) | 0/16 (0.0%) | 0/23 (0.0%) | 0/39 (0.0%) |
| B1 | 1/36 (2.8%) | 1/18 (5.6%) | 2/54 (3.7%) | 0/19 (0.0%) | 1/24 (4.2%) | 1/43 (2.3%) | 0/16 (0.0%) | 0/23 (0.0%) | 0/39 (0.0%) |
| B2 | 33/36 (91.7%) | 11/18 (61.1%) | 44/54 (81.5%) | 19/19 (100%) | 23/24 (95.8%) | 42/43 (97.7%) | 16/16 (100%) | 23/23 (100%) | 39/39 (100%) |
| B21 | 2/36 (5.6%) | 5/18 (27.8%) | 7/54 (13.0%) | 0/19 (0.0%) | 0/24 (0.0%) | 0/43 (0.0%) | 0/16 (0.0%) | 0/23 (0.0%) | 0/39 (0.0%) |
| D | 0/36 (0.0%) | 0/18 (0.0%) | 0/54 (0.0%) | 0/19 (0.0%) | 0/24 (0.0%) | 0/43 (0.0%) | 0/16 (0.0%) | 0/23 (0.0%) | 0/39 (0.0%) |
Fig. 4Distribution of pks and cnf1 genes and β-hemolysis according to phylogenetic group of E. coli isolates from macaques in 2014 and 2016
Serotype and virulence factors testing results of E. coli isolates from macaques
| Sample # | O type | H type |
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| S1 ( | 88 | 4 | NEG | NEG | NEG | NEG | NEG | NEG | POS | NEG |
| S2 ( | 88 | 4 | NEG | NEG | NEG | NEG | NEG | NEG | POS | NEG |
| S3 ( | 25 | 4 | NEG | NEG | NEG | NEG | NEG | NEG | POS | NEG |
| S6 ( | 25 | 4 | NEG | NEG | NEG | NEG | NEG | NEG | POS | NEG |
| S9 ( | 25 | 4 | NEG | NEG | NEG | NEG | NEG | NEG | POS | NEG |
| S10 ( | 25 | 4 | NEG | NEG | NEG | NEG | NEG | NEG | POS | NEG |
| S11 ( | 25 | 4 | NEG | NEG | NEG | NEG | NEG | NEG | POS | NEG |
| S4 ( | 7 | 7 | NEG | NEG | NEG | NEG | NEG | NEG | NEG | NEG |
| S5 ( | 7 | 7 | NEG | NEG | NEG | NEG | NEG | NEG | NEG | NEG |
| S7 ( | M | 14 | NEG | NEG | NEG | NEG | NEG | NEG | NEG | NEG |
| S8 ( | M | 16 | NEG | NEG | NEG | NEG | NEG | NEG | NEG | NEG |
Fig. 5a Cell culture assay for cytotoxicity. HeLa cells were treated with E. coli at a multiplicity of infection (MOI) between 1 and 100 for 4 h followed by a 72 h incubation in gentamicin-containing media. Cells infected with the novel rhesus macaque isolates encoding pks (S1, S2, S4, S5, S13, and S14) displayed megalocytosis (enlargement of the cell body and nucleus) similar to the pks+ E. coli controls (NC101 mouse isolate and V27 human urosepsis isolate). Isolates pks−/cnf1+ (S3, S9, and S10) did not induce megalocytosis, but caused elongated cell morphologies. No cytotoxicity was observed for cells treated with novel isolates pks−/cnf1− (S7, S8, and S12), the E. coli negative controls (media control and K12 non-pathogenic laboratory strain) as well as NC101 Δpks. Images were taken at 20× magnification. b Cell culture assay for cytotoxicity. HeLa cells were treated for 72 h with E. coli sonicate at a dose of 40 μg/mL total protein. Only treatment with sonicate from the cnf1-encoding novel rhesus macaque isolates (S1, S2, S3, S9, S10, and S14) caused cell body enlargement and multi-nucleation. No cytotoxicity was observed after sonicate treatment with the other novel isolates. Images were taken at 20× magnification
Genome characteristics
| Strain/isolate | Source | Genome length (bp) | Contigs | N50 | GC content (%) | Protein genes (CDS) | tRNA genes | rRNA genes | Virulence factor genes | Antibiotic resistance genes | GenBank accession |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S1 ( | Research rhesus macaque rectal swab | 5,070,329 | 92 | 268,704 | 50.49 | 5022 | 78 | 10 |
| – | NHZD00000000 |
| S2 ( | Research rhesus macaque rectal swab | 5,070,134 | 98 | 268,677 | 50.49 | 5017 | 78 | 10 |
| – | NHZC00000000 |
| S4 ( | Research rhesus macaque rectal swab | 4,843,133 | 160 | 65,852 | 50.72 | 4721 | 83 | 10 |
| – | NHZA00000000 |
| S5 ( | Research rhesus macaque rectal swab | 4,899,189 | 116 | 127,782 | 50.54 | 4791 | 81 | 10 |
| – | NHYZ00000000 |
| S3 ( | Research rhesus macaque rectal swab | 5,239,168 | 227 | 105,395 | 50.66 | 5403 | 80 | 8 |
|
| NHZB00000000 |
| S6 ( | Research rhesus macaque rectal swab | 5,345,115 | 176 | 178,747 | 50.53 | 5502 | 79 | 9 |
|
| NHYY00000000 |
| S9 ( | Research rhesus macaque rectal swab | 5,536,267 | 173 | 170,757 | 50.32 | 5765 | 81 | 9 |
|
| NHYV00000000 |
| S10 ( | Research rhesus macaque rectal swab | 5,254,454 | 178 | 113,006 | 50.70 | 5393 | 80 | 9 |
|
| NHYU00000000 |
| S7 ( | Research rhesus macaque rectal swab | 4,840,594 | 136 | 147,699 | 50.76 | 4807 | 84 | 10 |
| – | NHYX00000000 |
| S8 ( | Research rhesus macaque rectal swab | 4,770,474 | 119 | 168,371 | 50.68 | 4730 | 81 | 11 |
| – | NHYW00000000 |
| IHE3034 | Human neonatal meningitis | 5,108,383 | 1 (complete genome) | – | 50.70 | 5045 | 97 | 22 |
| – | CP001969.1 |
| NC101 | Research mouse intestinal commensal, pro-carcinogenic | 5,021,144 | 27 | 511,891 | 50.57 | 4917 | 72 | 4 |
| – | AEFA00000000.1 |
| UTI89 | Human uropathogenic strain | 5,179,971 | 1 (complete genome) | – | 50.60 | 5040 | 89 | 14 |
| – | CP000243.1 |
| K-12 substr. DH10B | Human non-pathogenic intestinal commensal | 4,686,137 | 1 (complete genome) | – | 50.80 | 4606 | 87 | 14 |
| – | AP012306.1 |
Fig. 6a In the draft genomes of four representative novel rhesus macaque isolates PCR-positive for the clbA and clbQ genes, complete pks pathogenicity islands were identified and had ≥ 98% sequence homology and identical syntenic relationships compared to prototype pks+ strains IHE3034 and NC101. Due to being draft genomes, the genes in pks pathogenicity islands were separated onto two different contigs for NC101 and the four novel isolates. No pks pathogenicity island genes were identified in the draft genomes of any of the pks− isolates. b In the draft genomes of six representative novel rhesus macaque isolates PCR-positive for cnf1, the hemolysin-cnf1 operon was identified and had ≥ 99% sequence homology and identical syntenic relationships compared to the prototype hemolysin-cnf1 operon of the human uropathogenic E. coli strain UTI89. Neither cnf1 nor any hemolysin genes belonging to this operon were detected in any of the draft genomes of the other representative novel isolates